Gamma and Alpha Chains of Human Fibrinogen Possess Sites Reactive with Human Platelet Receptors

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 1982 Mar 1

PMID 6281794

Citations 22

Authors

J Hawiger

S Timmons

M Kloczewiak

D D Strong

R F Doolittle

Affiliations

Soon will be listed here.

Abstract

Fibrinogen, a clottable plasma protein, agglutinates both prokaryotic cells (e.g., staphylococci) and eukaryotic cell fragments (e.g., platelets) through interaction with specific receptors. To identify the region of the fibrinogen molecule responsible for its interaction with human platelets, we prepared polypeptide chain subunits (alpha, beta, and gamma) of human fibrinogen by reduction and carboxymethylation. A mixture of the chains induced aggregation (clumping) of human platelets separated from plasma proteins and treated with ADP. When individual chains of fibrinogen were tested, gamma-chain multimers caused platelet aggregation at a molar concentration comparable with that of intact human fibrinogen. The beta chain remained inactive, and the alpha chain was 1/4th to 1/5th as reactive as the gamma chain. Monospecific antibody fragments against the gamma chain inhibited binding of 125I-labeled fibrinogen to the human platelet receptor and blocked aggregation of platelets induced by ADP in the presence of fibrinogen or gamma-chain multimers. These results indicate that the gamma chain of human fibrinogen bears the main site for interaction with the platelet receptor.

Citing Articles

A Novel Fibrinolytic Protein From : Purification, Identification, Antithrombotic Evaluation, and Mechanisms Investigation.

Liu H, Yang J, Li Y, Ma Y, Wang W, Zhong W Front Mol Biosci. 2022; 8:772419.

PMID: 35141276 PMC: 8819685. DOI: 10.3389/fmolb.2021.772419.

Blood compatibility assessment of polymers used in drug eluting stent coatings.

Szott L, Irvin C, Trollsas M, Hossainy S, Ratner B Biointerphases. 2016; 11(2):029806.

PMID: 27083991 PMC: 5014517. DOI: 10.1116/1.4944586.

Integrin-based therapeutics: biological basis, clinical use and new drugs.

Ley K, Rivera-Nieves J, Sandborn W, Shattil S Nat Rev Drug Discov. 2016; 15(3):173-83.

PMID: 26822833 PMC: 4890615. DOI: 10.1038/nrd.2015.10.

Integrin targeted therapeutics.

Millard M, Odde S, Neamati N Theranostics. 2011; 1:154-88.

PMID: 21547158 PMC: 3086618. DOI: 10.7150/thno/v01p0154.

DLBS1033, a protein extract from Lumbricus rubellus, possesses antithrombotic and thrombolytic activities.

Trisina J, Sunardi F, Suhartono M, Tjandrawinata R J Biomed Biotechnol. 2011; 2011:519652.

PMID: 21403877 PMC: 3051164. DOI: 10.1155/2011/519652.

References

Doolittle R, Schubert D, Schwartz S . Amino acid sequence studies on artiodactyl fibrinopeptides. I. Dromedary camel, mule deer, and cape buffalo. Arch Biochem Biophys. 1967; 118(2):456-67. DOI: 10.1016/0003-9861(67)90374-8. View

Hawiger J, Niewiarowski S, Gurewich V, Thomas D . Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J Lab Clin Med. 1970; 75(1):93-108. View

Weiss H, Rogers J . Fibrinogen and platelets in the primary arrest of bleeding. Studies in two patients with congenital afibrinogenemia. N Engl J Med. 1971; 285(7):369-74. DOI: 10.1056/NEJM197108122850703. View

Chen R, Doolittle R . - cross-linking sites in human and bovine fibrin. Biochemistry. 1971; 10(24):4487-91. DOI: 10.1021/bi00800a021. View

Lipinska I, Lipinski B, Gurewich V . Fibrinogen heterogeneity in human plasma. Electrophoretic demonstration and characterization of two major fibrinogen components. J Lab Clin Med. 1974; 84(4):509-16. View

Jenkins C, Meyer D, Dreyfus M, LARRIEU M . Willebrand factor and ristocetin. I. Mechanism of rustocetin-induced platelet aggregation. Br J Haematol. 1974; 28(4):561-78. DOI: 10.1111/j.1365-2141.1974.tb06675.x. View

Takagi T, Doolittle R . Amino acid sequence studies on plasmin-derived fragments of human fibrinogen: amino-terminal sequences of intermediate and terminal fragments. Biochemistry. 1975; 14(5):940-6. DOI: 10.1021/bi00676a010. View

Takagi T, Doolittle R . Amino acid sequence of the carboxy-terminal cyanogen bromide peptide of the human fibrinogen beta-chain: homology with the corresponding gamma-chain peptide and presence in fragment D. Biochim Biophys Acta. 1975; 386(2):617-22. DOI: 10.1016/0005-2795(75)90306-2. View

Niewiarowski S, Budzynski A, Lipinski B . Significance of the intact polypeptide chains of human fibrinogen in ADP-induced platelet aggregation. Blood. 1977; 49(4):635-44. View

10.

Doolittle R, Cassman K, Cottrell B, Friezner S, Hucko J, Takagi T . Amino acid sequence studies on the alpha chain of human fibrinogen. Characterization of 11 cyanogen bromide fragments. Biochemistry. 1977; 16(8):1703-9. DOI: 10.1021/bi00627a028. View

11.

Sixma J, Wester J . The hemostatic plug. Semin Hematol. 1977; 14(3):265-99. View

12.

Henschen A, Lottspeich F . Sequence homology between gamma-chain and beta-chain in human fibrin. Thromb Res. 1977; 11(6):869-80. DOI: 10.1016/0049-3848(77)90115-3. View

13.

Timmons S, Hawiger J . Separation of human platelets from plasma proteins including factor VIII VWF by a combined albumin gradient-gel filtration method using HEPES buffer. Thromb Res. 1978; 12(2):297-306. DOI: 10.1016/0049-3848(78)90300-6. View

14.

Watt K, Takagi T, Doolittle R . Amino acid sequence of the beta chain of human fibrinogen: homology with the gamma chain. Proc Natl Acad Sci U S A. 1978; 75(4):1731-5. PMC: 392413. DOI: 10.1073/pnas.75.4.1731. View

15.

Mustard J, Packham M, Kinlough-Rathbone R, Perry D, REGOECZI E . Fibrinogen and ADP-induced platelet aggregation. Blood. 1978; 52(2):453-66. View

16.

Marguerie G, Plow E, Edgington T . Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem. 1979; 254(12):5357-63. View

17.

Bennett J, Vilaire G . Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest. 1979; 64(5):1393-401. PMC: 371288. DOI: 10.1172/JCI109597. View

18.

Hawiger J, Parkinson S, Timmons S . Prostacyclin inhibits mobilisation of fibrinogen-binding sites on human ADP- and thrombin-treated platelets. Nature. 1980; 283(5743):195-7. DOI: 10.1038/283195a0. View

19.

Peerschke E, ZUCKER M, Grant R, Egan J, Johnson M . Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood. 1980; 55(5):841-7. View

20.

Niewiarowski S, Budzynski A, Morinelli T, Brudzynski T, Stewart G . Exposure of fibrinogen receptor on human platelets by proteolytic enzymes. J Biol Chem. 1981; 256(2):917-25. View